In this issue:
First use of topical B-VEC for ocular complications of DEB
In vivo CRISPR gene editing promising for inherited retinal blindness
Enhancing clinical infrastructure for the delivery of genetic therapies
Once off ixo-vec may replace regular anti-VEGF injections for wet AMD
Descartes-08 elicits long-term improvements in myasthenia gravis
Stem cell-derived dopaminergic grafts feasible for Parkinson’s disease
Natural killer cell therapy with logic-gated gene circuits for AML
Exa-cel functionally cures sickle cell disease
Exa-cel reduces transfusion dependence in β-thalassemia
Intrathecal gene therapy may slow progression of giant axonal neuropathy
RGX-202 under investigation for Duchenne muscular dystrophy
Please login below to download this issue (PDF)